CLEVELAND, July 15,
2024 /PRNewswire/ -- VisionAir Solutions (VAS), the
small company with a big idea for better therapeutic solutions,
proudly announces a significant milestone of custom developing over
600 patient-specific airway stents using our AI VisionAir 3D Stent
Software—helping save the lives of these patients. This achievement
marks the company's commitment to bringing technological innovation
to pulmonary medicine. Since its acquisition by Theken Companies
last year, VAS has over doubled its growth and continues to
demonstrate industry adoption and the advantages of personalized
healthcare.
VisionAir Solutions has custom
developed over 600 patient-specific airway stents using AI
VisionAir 3D Stent Software.
Utilizing its AI software and 3D printing technology, VAS has
revolutionized the production of silicone airway stents—tailoring
each implant to meet the unique anatomical requirements of
individuals. These stents play a crucial role in enhancing
respiratory function and improving the quality of life for patients
with complex airway conditions; patients who were previously forced
to surgically replace their "off the shelf" single lumen airway
stent every 90 days can now receive a custom stent that fits their
anatomy near to perfect, resulting in significant extended time
before replacement.
"We are thrilled to reach this milestone," said Randy Theken, Founder of Theken Companies. "It
underscores our dedication to pushing the boundaries of what is
possible in personalized medicine. Each stent represents a
life-changing solution, designed by the physician and manufactured
with anatomical precision, reflecting our ongoing commitment to
collaboration, innovation, and patient-centered care."
Additionally, VAS is excited to announce a strategic partnership
with Lazzaro Medical. The aligned goals and innovations of both
organizations revolve specifically around helping patients breathe
easier. The partnership aims to advance the Tracheobronchomalacia
(TBM) treatment options for both surgical and non-operative
candidates. While the relationship is still in its infancy, the
hope is to create industry-wide protocols for the evaluation and
treatment of the millions of patients suffering from TBM.
As VAS continues to expand its 3D stent footprint and
relationships, it is actively exploring new applications for its
technology to include custom t-tubes and more readily available
off-the-shelf patient matched airway stents (expected late
2024-early 2025).
To learn more about VisionAir Solutions, visit
www.visionairsolutions.com.
To learn more about Lazzaro Medical, visit www.lazzaromed.com.
About VisionAir Solutions:
VisionAir Solutions is a leading provider of innovative medical
solutions, specializing in personalized airway stents designed to
enhance respiratory function and improve patient quality of
life.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/visionair-solutions-celebrates-milestone-and-new-collaboration-302196880.html
SOURCE VisionAir Solutions